SIXTEENTH SUPPLEMENTAL INDENTURESixteenth Supplemental Indenture • November 3rd, 2022 • Bausch Health Companies Inc. • Pharmaceutical preparations • New York
This Sixteenth Supplemental Indenture, dated as of September 14, 2022 (this “Supplemental Indenture”), by and between Bausch Health Americas, Inc., a Delaware corporation (the “Company”), and The Bank of New York Mellon, as trustee (“Trustee”) under the Indenture referred to below.
FOURTEENTH SUPPLEMENTAL INDENTUREFourteenth Supplemental Indenture • November 3rd, 2022 • Bausch Health Companies Inc. • Pharmaceutical preparations • New York
This Fourteenth Supplemental Indenture, dated as of September 14, 2022 (this “Supplemental Indenture”), by and between Bausch Health Companies Inc., a corporation continued under the laws of the Province of British Columbia (the “Company”), and The Bank of New York Mellon, as trustee (“Trustee”) under the Indenture referred to below.
FIFTEENTH SUPPLEMENTAL INDENTUREFifteenth Supplemental Indenture • November 3rd, 2022 • Bausch Health Companies Inc. • Pharmaceutical preparations • New York
This Fifteenth Supplemental Indenture, dated as of September 28, 2022 (this “Supplemental Indenture”), by and between Bausch Health Companies Inc., a corporation continued under the laws of the Province of British Columbia (the “Company”), and The Bank of New York Mellon, as trustee (“Trustee”) under the Indenture referred to below.
